Therapeutic drug monitoring should play an important role in determining and maintaining the most optimal dose of anti-TNF agents for IBD patients, but needs MBS rebates to be more accessible, an expert says. Conjoint Associate Professor Susan Connor, senior staff specialist at Liverpool Hospital’s Department of Gastroenterology and Hepatology, presented to AGW 2016 held in ...
Therapeutic drug monitoring plays a key role in IBD management
By Amanda Sheppeard
20 Oct 2016